July 2020 New Boards of Directors at SEBBM The Governing Boards lead by the new President, Isabel Varela Nieto, at SEBBM include…
Welcome to the web site of the CellCOM Research Group (Consolidated Group A into INIBIC). We are a young and enthusiastic group that consists of several PhD students, postdoctoral fellows and clinical researchers within the Institute for Biomedical Research of A Coruña (INIBIC). The INIBIC is located at the Hospital (CH-Universitario of A Coruña, Spain). We use mammalian cell culture systems, ex vivo and in vivo assays and molecular, cellular and electrophysiological methods to investigate the functions of connexins and pannexins in cancer, inflammation and tissue regeneration.
Our aims are to understand the physiopathology of connexin-linked diseases, to design molecules and new drugs that modulate the activity of a specific protein and to identify novel markers of disease prevention, diagnosis and disease management.
We are focused on understanding the role of connexins and pannexins in osteoarthritis, skin wound healing in oncological patients, brain metastasis and resistance to targeted cancer therapy. Our final goal is to identify effective therapeutic targets to combat these disorders.